Coherus BioSciences, Inc.
Hedge Funds Holdings
Last updated:
Coherus BioSciences, Inc.‘s stocks are currently a part of 173 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 115.14M shares of Coherus BioSciences, Inc.. Compared to the previous quarter, the number fell by -0.73% or -848.92K shares fewer. As for the holding position changes, 33.53% (58) of current hedge fund investors increased the number of shares held, 39.31% (68) of current holders sold a part of the shares held, and 20.23% (35) closed the holdings completely. 19 hedge funds are new holders of Coherus BioSciences, Inc. stock in Q1 2022, it is 10.98% of total holders.
Hedge funds holding Coherus BioSciences (Q2 2017 – Q1 2022)
| Q2 2017 | 106 |
|---|---|
| Q3 2017 | 92 |
| Q4 2017 | 93 |
| Q1 2018 | 101 |
| Q2 2018 | 113 |
| Q3 2018 | 105 |
| Q4 2018 | 106 |
| Q1 2019 | 114 |
| Q2 2019 | 142 |
| Q3 2019 | 162 |
| Q4 2019 | 182 |
| Q1 2020 | 182 |
| Q2 2020 | 184 |
| Q3 2020 | 195 |
| Q4 2020 | 188 |
| Q1 2021 | 199 |
| Q2 2021 | 185 |
| Q3 2021 | 183 |
| Q4 2021 | 191 |
| Q1 2022 | 173 |
Hedge funds changes in Coherus BioSciences positions (Q2 2017 – Q1 2022)
| Q2 2017 | 20 | 53 | 21 | 22 | -10 |
|---|---|---|---|---|---|
| Q3 2017 | 8 | 44 | 24 | 21 | -5 |
| Q4 2017 | 15 | 36 | 27 | 14 | 1 |
| Q1 2018 | 21 | 39 | 29 | 12 | 0 |
| Q2 2018 | 26 | 48 | 25 | 14 | 0 |
| Q3 2018 | 7 | 49 | 38 | 15 | -4 |
| Q4 2018 | 23 | 39 | 30 | 22 | -8 |
| Q1 2019 | 23 | 42 | 31 | 15 | 3 |
| Q2 2019 | 41 | 47 | 40 | 11 | 3 |
| Q3 2019 | 42 | 54 | 43 | 20 | 3 |
| Q4 2019 | 44 | 69 | 48 | 17 | 4 |
| Q1 2020 | 29 | 71 | 63 | 27 | -8 |
| Q2 2020 | 49 | 64 | 56 | 45 | -30 |
| Q3 2020 | 33 | 82 | 57 | 21 | 2 |
| Q4 2020 | 23 | 68 | 68 | 29 | 0 |
| Q1 2021 | 34 | 75 | 64 | 22 | 4 |
| Q2 2021 | 22 | 82 | 55 | 36 | -10 |
| Q3 2021 | 20 | 53 | 77 | 21 | 12 |
| Q4 2021 | 33 | 52 | 73 | 22 | 11 |
| Q1 2022 | 19 | 58 | 68 | 35 | -7 |
Hedge funds changes in Coherus BioSciences stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 6,321,000 | 3,148,000 |
|---|---|---|
| Q3 2017 | 1,426,000 | 1,917,000 |
| Q4 2017 | 590,000 | 1,008,000 |
| Q1 2018 | 1,994,000 | 983,000 |
| Q2 2018 | 15,349,000 | 9,227,000 |
| Q3 2018 | 4,835,000 | 5,650,000 |
| Q4 2018 | 531,000 | 833,000 |
| Q1 2019 | 1,183,000 | 358,000 |
| Q2 2019 | 8,593,000 | 1,081,000 |
| Q3 2019 | 15,810,000 | 4,992,000 |
| Q4 2019 | 8,758,000 | 4,672,000 |
| Q1 2020 | 3,883,000 | 3,449,000 |
| Q2 2020 | 1,731,000 | 2,532,000 |
| Q3 2020 | 787,000 | 2,980,000 |
| Q4 2020 | 1,634,000 | 1,144,000 |
| Q1 2021 | 787,000 | 1,537,000 |
| Q2 2021 | 1,544,000 | 1,772,000 |
| Q3 2021 | 1,828,000 | 2,316,000 |
| Q4 2021 | 1,141,000 | 726,000 |
| Q1 2022 | 11,000 | 616,000 |